Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF 2023-08-30 08:03
Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development 2023-08-30 08:00
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:02
Datasea Announces Strategic Partnership with Sales and Marketing Firm for the Launch of Intelligent Acoustic Skin Repair Robot 2023-08-29 21:57
Akeso Announced Completion of Patient Enrollment in Phase 3 Trial of Ivonescimab (PD-1/VEGF) versus Pembrolizumab in First-line PD-L1 Positive Advanced NSCLC 2023-08-29 20:00
ProfoundBio to Participate in the 21st Annual Morgan Stanley Conference 2023-08-28 20:00
Harbour BioMed Announces 2023 Interim Results 2023-08-28 17:08
Meet Kuushy: Sit your way to better health 2023-08-28 16:46
Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors 2023-08-28 16:30
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan 2023-08-28 11:42
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy 2023-08-28 04:00
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial 2023-08-25 20:58
Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA 2023-08-25 20:00
Tigermed Reports 2023 Interim Results 2023-08-25 18:39
Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 clinical Trial of SK10, in Development for Treatment of Chemotherapy-induced Diarrhea 2023-08-25 18:19
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics 2023-08-25 15:14
Laekna, Inc. (2105.HK) Announces Interim Results 2023 2023-08-25 08:00
Ping An Health announces 2023 interim results 2023-08-24 21:00
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management 2023-08-24 20:00
Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA 2023-08-24 20:00
1 67 68 69 70 71 801